AI are (going to be) people too
BY KIM BELLARD My heart says I should write about Uvalde, but my head says, not yet; there are others more able to do that. […]
patent
ViiV claims $1.25bn settlement from Gilead in HIV patent dispute
A patent dispute between ViiV Healthcare and Gilead Sciences has been resolved, with Gilead agreeing to pay a $1.25 billion settlement as well as royalties […]
Appeals court reverses $1.2bn judgment against Gilead in BMS CAR-T case
Gilead Sciences’ Kite Pharma has won a key victory on appeal in its long-running dispute with Bristol-Myers Squibb over patents relating to CAR-T therapies, overturning […]
Expert Forum Examines the Patent Content Expansion Plan for Reaxys
User feedback is instrumental to the evolution of Reaxys. Not only in articulating what works and what is missing, but also in guiding the direction […]
“Mr. Biden is wrong”
That was the conclusion of The Economist on his decision to suspend intellectual property protections for the makers of COVID-19 vaccines. In the article “Ten […]
Alvotech files lawsuit challenging AbbVie’s Humira patent thicket
Biosimilars firm Alvotech has filed a lawsuit that challenges AbbVie’s legal defences surrounding the inflammatory disease drug Humira in the US. Alvotech is challenging the […]
Pfizer shares slump as support grows for COVID-19 vaccine patent waiver
Shares in COVID-19 vaccine manufacturers have taken a hit after the US signalled its support for waiving patents on them, a moved aimed to boost […]
Competitive Intelligence Gets a Boost with Reaxys Patent Expansion
The insights only found in patents can provide a crucial competitive advantage for innovative companies. In response to customer demand, Elsevier recently announced a major […]
Teva faces EU antitrust probe over MS drug Copaxone
The European Commission has formally opened an antitrust investigation into Teva, which will assess whether the pharma company illegally delayed launches and use of generic […]
AstraZeneca breathes sigh of relief as court blocks US Symbicort generic
A US court has upheld AstraZeneca’s patents on its respiratory drug Symbicort, blocking cheaper competition for the ageing blockbuster. The US District Court for the […]
EU fines Teva and Cephalon €60.5m for ‘pay for delay’ scheme
The European Union has fined Teva and its neurology unit Cephalon €60.5 million for an elaborate “pay for delay” scheme that prevented cheaper generic competition […]
Teladoc v. AmWell: 5 things to know
Teladoc Health has sued competitor American Well for patent infringement. The company is seeking unspecified damages and a ruling that would prevent AmWell from using […]
Chia Seeds vs. Flaxseeds
What effect do chia seeds have on weight loss, blood sugar, cholesterol, blood pressure, and inflammation? We’ve been eating chia seeds for more than […]
